Zeria Pharmaceutical Co (JP:4559) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Zeria Pharmaceutical Co. reported a strong financial performance for the first half of the fiscal year ending March 31, 2025, with net sales rising by 15.7% and operating profit increasing by 21.2% compared to the same period last year. The company also announced a dividend increase, reflecting its robust growth and financial health.
For further insights into JP:4559 stock, check out TipRanks’ Stock Analysis page.